Grilled Cheese

ExploreLog inSign up
Terms of UsePrivacy PolicyCommunity StandardsHelpGet the app

Grilled Cheese is a product of Village Compute

Version devBuilt at: 2026-10-10 01:38:52 EDT

Explore

PostsPeople
LatestRanked
@onclive.bsky.socialOct 2, 2026, 2:01 PM

Did you miss key updates in NSCLC, breast cancer, MDS, and PTLD? Test your knowledge with this week's OncLive news quiz #lcsm #bcsm #mpnsm #oncology

www.onclive.com/view/onclive...

@onclive.bsky.socialOct 1, 2026, 2:54 PM

📰Topline data from the phase 3 portion of the AZTOUND trial showed oral azacitidine and cedazuridine met the pharmacokinetic primary end point in patients with MDS or CMML #mpnsm #leusm #oncology

Read more: www.onclive.com/view/oral-az...

@eshaematology.bsky.socialSep 30, 2026, 8:53 AM

📣 #ESHCMLMPN2027: PROGRAMME HIGHLIGHT:
DEBATE 1 Do we need the term "accelerated phase" CML in the TKI era?
5th How to Diagnose and Treat CML/MPN
March 5-7, 2027/Prague, Czech Republic
Chairs: Claire Harrison, Andreas Hochhaus, Ruben Mesa
More info ➡ bit.ly/3Z8y3tI
#ESHCONFERENCES #MPNsm #CMLsm

@onclive.bsky.socialSep 28, 2026, 9:06 PM

⚛️ "What I would emphasize is the need to maintain dose intensity, and that should color how and which JAK inhibitor people use, rather than using suboptimal doses of drugs," said @raajitrampal.bsky.social of @mskcancercenter.bsky.social

Read more here ➡️: www.onclive.com/view/dose-in...

#mpnsm

@onclive.bsky.socialSep 11, 2026, 9:01 PM

Looking for more data on rusfertide in polycythemia vera following the FDA's August approval? Dive into a subgroup analysis of the VERIFY trial presented at #SOHO2026 #mpnsm #oncology www.onclive.com/view/rusfert...

@onclive.bsky.socialSep 11, 2026, 7:19 PM

📈MPN expert, Andrew Kuykendall, MD, of Moffitt Cancer Center, ranked these headlining novel treatments in MPNs at #SOHO2026.

‼️Visit our site for more: www.onclive.com/conference/s...

@societyofhemonc.bsky.social #mpnsm #oncology #hematology #cancer

@onclive.bsky.socialSep 11, 2026, 5:05 PM

WATCH 👀: Naseema Gangat, MBBS of @mayocliniccancer.bsky.social reviews cohort-specific hematologic response rates and safety findings for selcodebart in myelofibrosis from RALLY-MF.

See the whole video here ➡️: onclive.com/view/dr-gang...

#mpnsm #oncology #SOHO2026 @societyofhemonc.bsky.social

@onclive.bsky.socialSep 10, 2026, 3:19 PM

❓How did selcodebart perform in anemia-defined cohorts of patients with myelofibrosis?

See our site for the data readout of the RALLY-MF trial presented at #SOHO2026! @societyofhemonc.bsky.social #mpnsm #hematology

www.onclive.com/view/selcode...

@onclive.bsky.socialSep 9, 2026, 8:17 PM

2️⃣ conferences at once! Get ready for #SOHO2026 in Houston and #WCLC26 in Seoul!
🤠 Over the next few days, we’ll be covering the two conferences in-depth with expert insight all on our site! 🇰🇷
@societyofhemonc.bsky.social @iaslc.bsky.social #lcsm #leusm #mmsm #mpnsm #lymsm #oncology #hematology

@eshaematology.bsky.socialSep 8, 2026, 1:48 PM

📣 #ESHCMLMPN2027: REMINDER:
REGISTRATION AND ABSTRACT & CLINICAL CASE SUBMISSION ARE OPEN!
To proceed and for more info ➡ bit.ly/3Z8y3tI
5th How to Diagnose and Treat CML/MPN
March 5-7, 2027/Prague, Czech Republic
Chairs: Claire Harrison, Andreas Hochhaus, Ruben Mesa
#ESHCONFERENCES #MPNsm #CMLsm